Skip to main content
Have a personal or library account? Click to login
Prognostic value of some tumor markers in unresectable stage IV oropharyngeal carcinoma patients treated with concomitant radiochemotherapy Cover

Prognostic value of some tumor markers in unresectable stage IV oropharyngeal carcinoma patients treated with concomitant radiochemotherapy

Radiology and Oncology
Volume 49 (2015): Issue 4 (December 2015)
By: ,  ,  ,  ,  ,   and    
Open Access
|Nov 2015
References

References

  1. 1. Genden EM, Sambur IM, de Almeida JR. Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know.2013;405-16.
    Open DOISearch in Google Scholar
  2. 2. Smid L, Lesnicar H, Zakotnik B, Soba E, Budihna M, Furlan L, et al. Radiotherapy, combined with simultaneous chemotherapy wit h mitomycin C and bleomycin for inoperable head and neck cancer - preliminary report.1995;769-75.
    Open DOISearch in Google Scholar
  3. 3. Budihna M, Šoba E, Šmid L, Zakotnik B, Strojan P, Čemažar M, et al. Inoperable oropharyngeal carcinoma treated with concomitant irradiation, mitomycin C and bleomycin - long term results.2005;165-74.
    Search in Google Scholar
  4. 4. Fowler, JF. The linear quadratic formula and progress in fractionated radiotherapy.1998;679-94.
    Open DOISearch in Google Scholar
  5. 5. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.1958;457-89.
    Open DOISearch in Google Scholar
  6. 6. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples.1977;1-39.
    Open DOISearch in Google Scholar
  7. 7. Cox DR. Regression models and life tables.1972;187-220.
    Open DOISearch in Google Scholar
  8. 8. Kovac V, Zwitter M, Zagar T. Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients.2012;136-44.
    Open DOISearch in Google Scholar
  9. 9. Kudo Y, Takata T, Yasui W, Ogawa I, Miyauchi M, Takekoshi T, et al. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is an indicator of malignant behaviour in oral squamous cell carcinoma.1998;2447-55.
    Open DOISearch in Google Scholar
  10. 10. Shimada M, Kitagawa K, Dobashi Y, Isobe T, Hattori T, Uchida C, et al. High expression of Pirh2, an E3 ligase for p27, is associated with low expression of p27 and poor prognosis in head and neck cancers.2009;866-72.
    Open DOISearch in Google Scholar
  11. 11. Moreno-Galindo C, Hermsen M, García-Pedrero JM, Fresno MF, Suárez C, Rodrigo JP. p27 and BCL2 expression predicts response to chemotherapy in head and neck squamous cell carcinomas.2014;128-34.
    Open DOISearch in Google Scholar
  12. 12. Fillies T, Woltering M, Brandt B, Van Diest JP, Werkmeister R, Joos U, et al. Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas.2007;355-9.
    Open DOISearch in Google Scholar
  13. 13. Zhang M, Li J, Wang L, Tian Z, Zhang P, Xu Q, et al. Prognostic significance of p21, p27 and survivin protein expression in patients with oral squamous cell carcinoma.2013;381-6.
    Open DOISearch in Google Scholar
  14. 14. O‘Rourke RW, Miller CW, Kato GJ, Simon KJ, Chen DL, Dang CV, et al. A potential transcriptional activation element in the p53 protein.1990;1829-32.
    Search in Google Scholar
  15. 15. Wu X, Zhong D, Lin B, Zhai W, Ding Z, Wu J. p38 MAPK regulates the expression of ether a go-go potassium channel in human osteosarcoma cells.2013;42-9.
    Open DOISearch in Google Scholar
  16. 16. Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones TM. A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck.2010;574-87.
    Open DOISearch in Google Scholar
  17. 17. Awwad S, Jaros E, Somes J, Lunec J. P53 overexpression in head and neck carcinoma and radiotherapy results.1996;323-32.
    Open DOISearch in Google Scholar
  18. 18. Grabenbauer GG, Muhlfriedel C, Roedel F, Niedobitek G, Hornung J, Roedel C, et al. Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy.2000;1041-50.
    Open DOISearch in Google Scholar
  19. 19. Otero-Garcia J E, Youssef E, Enamorado I, Du W, Yoo G H, Merati K, et al. Prognostic significance of p53 and FHIT in advanced oropharyngeal carcinoma2004;231-9.
    Search in Google Scholar
  20. 20. Ribeiro DA, Nascimento FD, Fracalossi ACC, Gomes TS, Oshima CT, Franco MF. Expression profiling of cell cycle regulatory proteins in oropharyngeal carcinomas using tissue microarrays.2010;315-20.
    Search in Google Scholar
  21. 21. Erber R, Klein W, Andl T, Enders C, Born AI, Conradt C, et al. Aberrant p21 (CIP1/WAF1) protein accumulation in head-and-neck cancer..1997;383-9.
    Open DOISearch in Google Scholar
  22. 22. Hafkamp HC, Mooren JJ, Claessen SM, Klingenberg B, Voogd AC, Bot FJ, et al. P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis.2009;686-98.
    Open DOISearch in Google Scholar
  23. 23. Chung YL, Lee MY, Horng C, Jian JJ, Cheng SH, Tsai SY, et al. Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiotherapy alone.2009;9-20.
    Open DOISearch in Google Scholar
  24. 24. Perisanidis C, Perisanidis B, Wrba F, Brandstetter A, El Gazzar S, Papadogeorgakis N, et al. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.2012;40-6.
    Open DOISearch in Google Scholar
  25. 25. Yu Z, Paul PM,. Haffty BG, Sasaki C, Zerillo C, Joe J, et al. Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma.2005;1160-6.
    Open DOISearch in Google Scholar
  26. 26. Rahimi AS, Wilson DD, Saylor DK, Stelow EB, Thomas CY, Reibel JF, et al. p16, cyclin D1, and HIF-1α predict outcomes of patients with oropharyngeal squamous cell carcinoma treated with definitive intensity-modulated radiation therapy.. 2012 (2012); Article ID 685951, 9 p. doi: 10.1155/2012/685951.
    Open DOISearch in Google Scholar
  27. 27. Koelbl O, Rosenwald A, Haberl M, Müller J, Reuther J, Flentje M. P53 and KI-67 as predictive markers for radiosensitivity in squamous cell carcinoma of the oral cavity. An immunohistochemical and clinicopathologic study.2001;147-54.
    Open DOISearch in Google Scholar
  28. 28. Watanabe S, Watanabe R, Oton-Leite AF, Alencar Rde C, Oliveira JC, Leles CR, et al. Analysis of cell proliferation and pattern of invasion in oral squamous cell carcinoma.2010;417-24.
    Open DOISearch in Google Scholar
  29. 29. Pereira CS, Oliveira MV, Fraga CA, Barros LO, Domingos PL, Roy A, et al. Impact of the epithelial dysplasia grading and Ki67 proliferation index in the adjacent non-malignant mucosa on recurrence and survival in head and neck squamous cell carcinoma.2012;651-6.
    Open DOISearch in Google Scholar
  30. 30. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.2002;7350-6.
    Search in Google Scholar
  31. 31. Semrau R, Duerbaum H, Temming S, Huebbers C, Stenner M, Drebber U, et al. Prognostic impact of human papillomavirus status, survivin, and epidermal growth factor receptor expression on survival in patients treated with radiochemotherapy for very advanced nonresectable oropharyngeal cancer.2013;1339-44.
    Open DOISearch in Google Scholar
  32. 32. Ataman OU, Bentzen SM, Wilson GD, Daley FM, Richman PI, Saunders MI, et al. Molecular biomarkers and site of first recurrence after radiotherapy for head and neck cancer.2004;2734-41.
    Open DOISearch in Google Scholar
  33. 33. Chuang HC, Su CY, Huang HY, Chien CY, Chen CM, Huang CC. High Expression of CD105 as a prognostic predictor of early tongue cancer.2006;1175-9.
    Open DOISearch in Google Scholar
  34. 34. Foote RL, Weidner N, Harris J, Hammond E, Lewis JE, Vuong T, et al. Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505.2005;745-53.
    Open DOISearch in Google Scholar
  35. 35. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer.2010;24-35.
    Open DOISearch in Google Scholar
  36. 36. Spanos WC, Nowicki P, Lee DW, Hoover A, Hostager B, Gupta A, et al. Immune response during therapy with cisplatin of radiation for human papillomavirus related head and neck cancer.2009;1137-46.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/raon-2014-0048 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 365 - 370
Submitted on: Oct 13, 2014
Accepted on: Nov 15, 2014
Published on: Nov 27, 2015
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
oropharynx,
radiochemotherapy,
tumor markers
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2015 Erika Soba, Marjan Budihna, Lojze Smid, Nina Gale, Hotimir Lesnicar, Branko Zakotnik, Primoz Strojan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 49 (2015): Issue 4 (December 2015)
Previous article
Next article